DNMT3A and myelodysplastic syndrome: In these patients, the risk of direct evolution of DNMT3A–clonal hematopoiesis to donor cell leukemia (DCL) is low, and most DCLs were traced to atypical donor clonal hematopoiesis involving myelodysplastic syndrome–associated (MDS-associated) genes or germline risk alleles (15).